Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $141.0K | $437.3K | $942.2K | $902.9K | $1.9M | $7.2M | $11.0M | $12.2M |
| Cost of revenue | $75.7K | $175.5K | $398.2K | $341.3K | $1.9M | $4.1M | $6.5M | $6.9M |
| Gross profit | $65.3K | $261.9K | $544.0K | $561.6K | −$56.8K | $3.1M | $4.5M | $5.4M |
| Gross margin | 46.3% | 59.9% | 57.7% | 62.2% | -3.0% | 43.0% | 40.9% | 44.0% |
| R&D | $64.0K | $259.5K | $231.8K | $194.3K | $161.0K | $64.4K | $193.8K | $150.7K |
| Operating income | −$3.9M | −$5.3M | −$6.1M | −$8.9M | −$8.6M | −$10.5M | $432.7K | −$4.3M |
| EBITDA | −$4.6M | −$5.2M | −$7.5M | −$10.0M | −$8.3M | −$9.7M | −$6.1M | −$3.9M |
| Net income | −$5.7M | −$5.3M | −$7.8M | −$11.1M | −$8.6M | −$24.7M | −$30.3M | $158.0K |
| Net margin | -4076.0% | -1213.0% | -824.4% | -1233.4% | -453.9% | -342.1% | -274.0% | 1.3% |
| EPS (diluted) | -78.66 | -72.60 | -105.09 | -91.61 | -180.53 | -52.23 | -27.01 | 0.12 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds GHSI.
No tracked institution reports a position in GHSI as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2024-09-24 | $5.0000 | 2024-09-23 |
| Execution date | Ratio |
|---|---|
| 2023-01-09 | 1-for-50reverse |
| 2021-03-01 | 1-for-6reverse |
No one on the platform has traded GHSI yet.
| $5M |
| — |
| HDRPFEpsilon Healthcare Limited | $0.00 | +0.00% | $544746 | — |
| HERTFHeritage Cannabis Holdings Corp. | $0.00 | +40.00% | $3M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.3× sales vs its 1.1× historical median P/S.
Fair value ≈ $10.41 · price $3.22 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
@Toontje1 Can you shed any correlation on what BO packages typically look like for the CEO of a company and the shares they own prior? Also, which stage(s) $GHSI is at within their trial(s) comparatively?
View on StockTwits ↗$GHSI this stock made my friend bear homeless and I am mildly upset about that
View on StockTwits ↗$GHSI anyone receive a $0.10/share dividend today? It said it's because I owned shares on 10/29/24. Am I the only one? Of course no one at GHSI can be contacted. Anyone have Bret's #?
View on StockTwits ↗$GHSI @Morgo you get another dividend from this? Great, just what I needed
View on StockTwits ↗$GHSI Dive into Algoland! Join the Algorand Foundation’s 13-week onchain adventure, starting Sept 22, 2025. Complete fun quests on top DApps, earn points, and win big—100,000 ALGO, a vacation, or an e-bike! Use my link to start! https://tinyurl.com/Algoland
View on StockTwits ↗$GHSI big exposure for CYDY at 3 oncology conferences this week, do your dd research
View on StockTwits ↗$RNAZ $RNAZ: If you need to blame someone for the current stock price of $RNAZ, then blame this guy: @Love_To_Learn who calls himself the Grid Master. I know him since 2021 when he brought down $GHSI from $8.40 to below $0.12 wiping out a ton of retail investors’ investments including mine. Unfortunately, I didn’t know this SOB aka @Love_To_Learn is involved in $RNAZ. Instead of reaching $20 or $5 or even $1, @Love_To_Learn made it certain for a RS. I’m tagging his arch-enemy @vaselineguy who knows him for a longer period. Since 2021, I don’t touch a stock in which @Love_To_Learn is involved.
View on StockTwits ↗The $GHSI comparison is garbage! Yes, Guardion did announce a liquidating distribution, but it was a completely different scale of business… 1. Share count was smaller 2. They had minimal debt and minimal burn 3. Most importantly: it was a fully disclosed and committed cash return, with a set per-share value and a timeline MURA has none of that. No plan. No deal. No guarantee. Just a vague “review.” You can wait for a “special dividend” that never shows.
View on StockTwits ↗$GHSI need help on GHSI. I didn’t sold the shares last year. From robinhood statement it’s not showing my 30k loss for 2024 taxes year. Any suggestions, currently it’s delisted. How can I claim my losses in 2024 ?
View on StockTwits ↗$GHSI Interesting play with Viactiv sale. Focusing on ocular health now. Management seems strategic about potential liquidation. Could see value unlock if dissolution plan moves forward. Might take a small position to monitor potential shareholder distributions. engaging article: https://beyondspx.com/article/guardion-health-sciences-ghsi-navigating-the-evolving-ocular-health-landscape
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.